p27kip1 Expression in Rectal Cancer Correlates with Disease-Free Survival
- 31 July 2000
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 92 (1) , 78-84
- https://doi.org/10.1006/jsre.2000.5871
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prognostic significance of p27Kip1 expression in colorectal cancer: a clinico-pathological characterizationThe Journal of Pathology, 1999
- p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human CancersThe American Journal of Pathology, 1999
- Down-Regulation of p27 Is Associated with Development of Colorectal Adenocarcinoma MetastasesThe American Journal of Pathology, 1998
- Influence of surgery on metachronous distant metastases and survival in rectal cancer.Journal of Clinical Oncology, 1998
- Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1The EMBO Journal, 1997
- Cyclin E-CDK2 is a regulator of p27Kip1.Genes & Development, 1997
- Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomasNature Medicine, 1997
- Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cellsNature, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994